Datopotamab deruxtecan: A novel antibody drug conjugate for triple-negative breast cancer
Article in Heliyon (March 2024)
The most recent citing publications are shown below. View all 163 publications that cite this research output on Dimensions.
Article in Heliyon (March 2024)
Article in International Immunopharmacology (February 2024)
Article in Scientific Reports (February 2024)